Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Assets    
Equity method investments $ 461,159 $ 522,615
Government receivables 511,700 519,485
Commercial receivables 468,402 473,452
Receivables held-for-sale 18,078 19,081
Real estate 355,200 340,824
Investments 153,612 151,209
Cash and cash equivalents 41,812 57,274
Other assets 208,044 166,232
Total Assets 2,218,007 2,250,172
Liabilities:    
Accounts payable, accrued expenses and other 24,772 25,645
Deferred funding obligations 97,685 153,308
Credit facility 102,939 69,922
Non-recourse debt (secured by assets of $1,503 million and $1,545 million, respectively) 1,198,256 1,210,861
Convertible notes 147,959 147,655
Total Liabilities 1,571,611 1,607,391
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 52,728,327 and 51,665,449 shares issued and outstanding, respectively 527 517
Additional paid in capital 789,129 770,983
Accumulated deficit (150,624) (131,251)
Accumulated other comprehensive income (loss) 3,855 (1,065)
Non-controlling interest 3,509 3,597
Total Stockholders’ Equity 646,396 642,781
Total Liabilities and Stockholders’ Equity $ 2,218,007 $ 2,250,172